recombinant adenovirus vector vaccine (Vaxin/AnC Bio)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Namerecombinant adenovirus vector vaccine (Vaxin/AnC Bio)

Drug Alias NameAdPEDI-(amyloid-beta1-6)11Alzheimer's disease vaccine (Vaxin)

ClassificationVaccines > Application > Therapeutic vaccineVaccines > Development/production technology > Recombinant vector vaccine

Mechanisms of ActionBeta amyloid A4 protein aggregation inhibitors

TargetsBeta amyloid A4 protein

Therapy Area/IndicationsAlzheimer Disease

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited StatesSouth Korea

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesAltimmune Inc

China Registration ClassN/A

Active CompaniesN/A

Active IndicationsN/A

Inactive IndicationsAlzheimer Disease

ATC CodeN/A